Judy C. Boughey

Also affiliated with WinnMed, Mayo Clinic in Arizona, Mayo Clinic in Florida, American College of Surgeons

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 58 papers. Top paper: “Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer”.

Association of Event-Free and Distant Recurrence–Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2020.2535

N/A

6.3DataRank · unranked

225 citations

Angela DeMichele, Christina Yau, Claudine Isaacs, W. Fraser Symmans, Kathy S. Albain +74 more

Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(22)00613-1

N/A

5.1DataRank · unranked

163 citations

Benjamin D. Smith, Savitri Krishnamurthy, Wei Yang, Vicente Valero, Yu Shen +31 more

Impact of the COVID-19 Pandemic on Cancer Clinical Trials

Annals of Surgical Oncology(2021)10.1245/s10434-021-10406-2

N/A

2.6DataRank · unranked

41 citations

Rebecca A. Snyder, Olga Kantor, Linda Zheng, Akhil Chawla, Toan T. Nguyen +5 more

Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

Cancer Research(2021)10.1158/0008-5472.can-20-2960

N/A

1.7DataRank · unranked

46 citations

Michelle E. Howard, Xinyi Tu, Qian Zhu, Janet M. Denbeigh, Nicholas B. Remmes +12 more

Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03267-1

N/A

1.4DataRank · unranked

43 citations

Meghna S. Trivedi, Christina Yau, Rita Nanda, Hope S. Rugo, Marie Davidian +55 more

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

Nature Communications(2023)10.1038/s41467-023-37806-0

N/A

1.4DataRank · unranked

44 citations

Saranya Chumsri, Douglas Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh +21 more

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

NAR Cancer(2022)10.1093/narcan/zcac018

N/A

1.3DataRank · unranked

44 citations

Roberto A. Leon‐Ferre, Jason P. Sinnwell, David Zahrieh, Vera J. Suman, Filho Otto Metzger +15 more

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients

The Lancet Oncology(2021)10.1016/s1470-2045(21)00589-1

N/A

0.917DataRank · unranked

451 citations

Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze +94 more

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer

npj Breast Cancer(2022)10.1038/s41523-022-00493-z

N/A

0.900DataRank · unranked

27 citations

Andres Forero‐Torres, Douglas Yee, Christina Yau, Denise M. Wolf, John Park +44 more

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Cancer Cell(2021)10.1016/j.ccell.2021.05.009

N/A

0.873DataRank · unranked

337 citations

Christina Yau, Denise M. Wolf, Hyo S. Han, Lili Du, Anne M. Wallace +40 more

Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

Journal of Clinical Oncology(2024)10.1200/jco.24.01052

N/A

0.825DataRank · unranked

43 citations

Alison Laws, Massimo Ferrucci, Mary M. Mrdutt, Susie X. Sun, Süleyman Bademler +95 more

Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(23)00388-1

N/A

0.821DataRank · unranked

30 citations

Sharmila Giri, Briant Fruth, Nicholas B. Remmes, Judy C. Boughey, Christin A. Harless +17 more

Primary and secondary angiosarcoma of the breast: The Mayo Clinic experience

Journal of Surgical Oncology(2010)10.1002/jso.21497

N/A

0.743DataRank · unranked

141 citations

Carol A. Reynolds, Amy C. Degnim, Ivy A. Petersen, James W. Jakub, Judy C. Boughey +1 more

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer

Journal of Clinical Oncology(2020)10.1200/jco.19.02190

N/A

0.709DataRank · unranked

112 citations

Chunling Hu, Steven N. Hart, Nicholas Boddicker, Eric C. Polley, Jie Na +22 more

FOXA1 overexpression suppresses interferon signaling and immune response in cancer

Journal of Clinical Investigation(2021)10.1172/jci147025

N/A

0.678DataRank · unranked

91 citations

Liguo Wang, Ting Wei, Yu‐Tian Xiao, Haoyue Sheng, Hengchuan Su +24 more

Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.33933

N/A

0.652DataRank · unranked

12 citations

Heather Lin, Yu Shen, Emilia J. Diego, Savitri Krishnamurthy, Wei Yang +32 more

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial

Nature Communications(2021)10.1038/s41467-021-26019-y

N/A

0.648DataRank · unranked

74 citations

Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, L. J. van ‘t Veer, Douglas Yee +46 more

MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Academic Radiology(2020)10.1016/j.acra.2020.10.020

N/A

0.624DataRank · unranked

63 citations

Daniel Gomez‐Cardona, Christopher Favazza, Tanya L. Hoskin, Tufia C. Haddad, Matthew P. Goetz +2 more

Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Nature Medicine(2024)10.1038/s41591-024-03266-2

N/A

0.610DataRank · unranked

13 citations

Jane Meisel, Christina Yau, Hope S. Rugo, Rita Nanda, Marie Davidian +52 more

Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy

Annals of Oncology(2021)10.1016/j.annonc.2021.02.011

N/A

0.574DataRank · unranked

45 citations

Christina Yau, Lamorna Brown Swigart, Rebekah Gould, Gregor Krings, Gillian L. Hirst +27 more

Early assessment of shear wave elastography parameters foresees the response to neoadjuvant chemotherapy in patients with invasive breast cancer

Breast Cancer Research(2021)10.1186/s13058-021-01429-4

N/A

0.550DataRank · unranked

38 citations

Eric C. Polley, Max Denis, Jodi M. Carter, Sandhya Pruthi, Adriana Gregory +5 more

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

npj Breast Cancer(2021)10.1038/s41523-021-00337-2

N/A

0.510DataRank · unranked

29 citations

Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar +50 more

Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer

Annals of Surgical Oncology(2023)10.1245/s10434-022-12972-5

N/A

0.464DataRank · unranked

21 citations

Vera J. Suman, Hannah F. Wingate, A. Marilyn Leitch, Gary Unzeitig, Judy C. Boughey +4 more

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2256

N/A

0.457DataRank · unranked

20 citations

Christina Yau, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien +44 more

Individualized-thresholding Shear Wave Elastography combined with clinical factors improves specificity in discriminating breast masses

The Breast(2020)10.1016/j.breast.2020.10.013

N/A

0.425DataRank · unranked

16 citations

Eric C. Polley, Redouane Ternifi, Rohit Nayak, Judy C. Boughey, Robert T. Fazzio +3 more

Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study

The Lancet Oncology(2025)10.1016/s1470-2045(25)00598-4

N/A

0.416DataRank · unranked

15 citations

Michael Alvarado, Sara Myers, Mary M Mrdutt, Susie X. Sun, Varadan Sevilimedu +95 more

Commentary and Updates on the Management of Male Breast Cancer

Annals of Surgical Oncology(2025)10.1245/s10434-024-16756-x

N/A

0.269DataRank · unranked

5 citations

Austin D. Williams, Anna Weiss, Collaborators from the Society of Surgical Oncology Breast Disease Site Work Group, Oluwadamilola M. Fayanju, Doreen M. Agnese +7 more

Pexidartinib and standard neoadjuvant therapy in the adaptively randomized I-SPY2 trial for early breast cancer

Breast Cancer Research and Treatment(2024)10.1007/s10549-024-07555-9

N/A

0.255DataRank · unranked

4 citations

Mike Campbell, Christina Yau, A. Jo Chien, Anne M. Wallace, Claudine Isaacs +18 more

Quantitative analysis of tyrosine phosphorylation from FFPE tissues reveals patient specific signaling networks

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.10.291922

N/A

0.184DataRank · unranked

2 citations

Danielle M. Burgenske, Ann C. Mladek, Katrina K. Bakken, Jenevieve Kuang, Judy C. Boughey +7 more

Oral paclitaxel and dostarlimab with or without trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant ISPY 2 TRIAL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.17_suppl.lba612

N/A

0.165DataRank · unranked

2 citations

Alexandra Thomas, Christina Yau, A. Jo Chien, Carla I. Falkson, Erica Stringer-Reasor +15 more

Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.17_suppl.lba520

N/A

0.165DataRank · unranked

2 citations

Kevin Kalinsky, Christina Yau, A. Jo Chien, Judy C. Boughey, Erica Stringer-Reasor +15 more

Role of intratumoral NK cells in triple-negative breast cancer in the FinXX trial and Mayo Clinic cohort.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.510

N/A

0.165DataRank · unranked

2 citations

Jodi M. Carter, Yaohua Ma, Douglas Hinerfeld, Heather Ann Brauer, Sarah Warren +15 more

355P Reduction of anthracycline use with a combined imaging and pathology prediction model in the neoadjuvant I-SPY2 trial

Annals of Oncology(2023)10.1016/j.annonc.2023.09.534

N/A

0.165DataRank · unranked

2 citations

Elizabeth Price, Sara J. Venters, Wěi Li, Denise M. Wolf, Jessica Gibbs +14 more

356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study

Annals of Oncology(2023)10.1016/j.annonc.2023.09.535

N/A

0.104DataRank · unranked

1 citations

Helena Earl, Christina Yau, David Cameron, Jean Abraham, Larry Hayward +15 more

Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial

Annals of Surgical Oncology(2025)10.1245/s10434-025-17864-y

N/A

0.104DataRank · unranked

1 citations

Katrina Dimitroff, Judy C. Boughey, Laura J. Esserman, Christina Yau, Julia Tchou +34 more

Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer

npj Breast Cancer(2024)10.1038/s41523-024-00629-3

N/A

0.104DataRank · unranked

1 citations

Jodi M. Carter, David M. Zahrieh, Jason P. Sinnwell, Roberto Salgado, Vera J. Suman +10 more

Patient-Derived Xenograft Engraftment and Breast Cancer Outcomes in a Prospective Neoadjuvant Study (BEAUTY)

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0641

N/A

0DataRank · unranked

20 citations

Vera J. Suman, Jia Yu, Katelyn Santo, Jason P. Sinnwell, Jodi M. Carter +15 more

Accuracy of breast MRI in evaluating nodal status after neoadjuvant therapy in invasive lobular carcinoma

npj Breast Cancer(2021)10.1038/s41523-021-00233-9

N/A

0DataRank · unranked

23 citations

Heather Greenwood, Tatiana Kelil, Ruby Guo, Case Brabham, Nola M. Hylton +7 more

Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer

Breast Cancer Research and Treatment(2023)10.1007/s10549-023-07152-2

N/A

0DataRank · unranked

11 citations

Tanya L. Hoskin, Courtney N. Day, Amy K. Schulze, Matthew P. Goetz, Judy C. Boughey +1 more

Data from Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

(2023)10.1158/0008-5472.c.6513031.v1

N/A

0DataRank · unranked

0 citations

Michelle E. Howard, Xinyi Tu, Qian Zhu, Janet M. Denbeigh, Nicholas B. Remmes +12 more

Data from Inhibition of ATM Induces Hypersensitivity to Proton Irradiation by Upregulating Toxic End Joining

(2023)10.1158/0008-5472.c.6513031

N/A

0DataRank · unranked

0 citations

Michelle E. Howard, Xinyi Tu, Qian Zhu, Janet M. Denbeigh, Nicholas B. Remmes +12 more

Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance

Oncogene(2021)10.1038/s41388-021-01711-x

N/A

0DataRank · unranked

103 citations

Tufia C. Haddad, Jeffrey L. Salisbury, Derek C. Radisky, Minzhi Zhang, Mark A. Schroeder +16 more

Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance)

UNC Libraries(2020)10.17615/vv76-g942

N/A

0DataRank · unranked

0 citations

Thomas A. Buchholz, Bruce G. Haffty, Reshma Jagsi, Sarah A. McLaughlin, Karla V. Ballman +4 more

Ultrasound-based quantitative microvasculature imaging for early prediction of response to neoadjuvant chemotherapy in patients with breast cancer

Breast Cancer Research(2025)10.1186/s13058-025-01978-y

N/A

0DataRank · unranked

5 citations

Nicholas B. Larson, Judy C. Boughey, Daniela Stan, Malvika Solanki, Robert T. Fazzio +3 more

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

UNC Libraries(2025)10.17615/h225-mq92

N/A

0DataRank · unranked

0 citations

Daniel G. Stover, David Zahrieh, Matthew P. Goetz, Eric W. Klee, Lisa A. Carey +15 more

Interferon signaling and outcomes in triple-negative breast cancer (TNBC) in FinXX, CALGB 40603 (Alliance) and real-world clinico-genomic data.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.569

N/A

0DataRank · unranked

0 citations

Yi Liu, Sachin Kumar Deshmukh, Jodi M. Carter, Heikki Joensuu, Roberto A. Leon‐Ferre +15 more

Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants’ and Program Directors’ Preferences Regarding In-Person Versus Virtual Interviews

Annals of Surgical Oncology(2025)10.1245/s10434-025-18043-9

N/A

0DataRank · unranked

0 citations

Richard J. Bleicher, Judy C. Boughey, Julie A. Margenthaler, Holly Mason, Catherine Pesce +61 more

Ultrasound high-definition microvasculature imaging with novel quantitative biomarkers improves breast cancer detection accuracy

European Radiology(2022)10.1007/s00330-022-08815-2

N/A

0DataRank · unranked

37 citations

Yinong Wang, Juanjuan Gu, Eric C. Polley, Jodi M. Carter, Sandhya Pruthi +5 more

Regulation of sister chromatid cohesion by nuclear PD-L1

Cell Research(2020)10.1038/s41422-020-0315-8

N/A

0DataRank · unranked

122 citations

Bo Qin, Ann M. Moyer, Somaira Nowsheen, Xinyi Tu, Haidong Dong +6 more

Hybrid high-definition microvessel imaging/shear wave elastography improves breast lesion characterization

Breast Cancer Research(2022)10.1186/s13058-022-01511-5

N/A

0DataRank · unranked

25 citations

Redouane Ternifi, Nicholas B. Larson, Jodi M. Carter, Judy C. Boughey, Daniela Stan +4 more

Identification of Src Family Kinases as Potential Therapeutic Targets for Chemotherapy-Resistant Triple Negative Breast Cancer

Cancers(2022)10.3390/cancers14174220

N/A

0DataRank · unranked

24 citations

Jia Yu, Yongxian Zhuang, Xiaoyang Fan, Raven J. Reddy, Jason P. Sinnwell +7 more

Treatment Efficacy Score—continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials

Annals of Oncology(2022)10.1016/j.annonc.2022.04.072

N/A

0DataRank · unranked

21 citations

Anna Mrukwa, Christina Yau, Denise M. Wolf, Y.-Y. Chen, Ronald Balassanian +26 more

Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer

Molecular Therapy — Oncolytics(2022)10.1016/j.omto.2022.11.002

N/A

0DataRank · unranked

16 citations

Robert J. Stiles, Gennett M. Pike, Laura A. Sikkink, Yongxian Zhuang, Jia Yu +5 more

Exploring homologous recombination deficiency thresholds for predicting response to platinum-based treatment in triple negative breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.525

N/A

0DataRank · unranked

0 citations

Lauren Lenz, Elizabeth S. Cogan, Erica L. Mayer, Virginia Kaklamani, Vered Stearns +15 more

Long-term outcomes of patients with node-negative (N0), triple-negative breast cancer (TNBC) who did not receive adjuvant chemotherapy according to stromal TILs (sTILs).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.548

N/A

0DataRank · unranked

0 citations

Jodi M. Carter, David W. Hillman, Kathleen Tenner, David M. Zahrieh, Minetta C. Liu +7 more

Changes in Surgical Management of the Axilla Over 11 Years – Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial

Annals of Surgical Oncology(2023)10.1245/s10434-023-13759-y

N/A

0DataRank · unranked

42 citations

Hongmei Yu, Catherine Lu Dugan, Mara A. Piltin, Lauren M. Postlewait, Jennifer D. Son +32 more

Establishment and characterization of immortalized human breast cancer cell lines from breast cancer patient-derived xenografts (PDX)

npj Breast Cancer(2021)10.1038/s41523-021-00285-x

N/A

0DataRank · unranked

12 citations

Jordan Grainger, Peter T. Vedell, Jia Yu, Ann M. Moyer, Huanyao Gao +9 more

Prediction of Invasive Breast Cancer Using Mass Characteristic Frequency and Elasticity in Correlation with Prognostic Histologic Features and Immunohistochemical Biomarkers

Ultrasound in Medicine & Biology(2021)10.1016/j.ultrasmedbio.2021.03.039

N/A

0DataRank · unranked

16 citations

Eric C. Polley, Judy C. Boughey, Robert T. Fazzio, Mostafa Fatemi, Azra Alizad +1 more